August 8, 2024 A Kaplan-Meier view of oncology development By Jason Brauner Biopharma, Consumer Health, Diagnostics, Digital Health, In the News Read More
February 7, 2024 Trends in biotech deals in 2022 and 2023: oncology vs. the rest By Jason Brauner Biopharma Read More
August 19, 2022 An innovative sales strategy for a pivotal drug; Novartis trailblazes with Leqvio By Jason Brauner Biopharma Read More
July 18, 2022 Looking into the crystal ball – What is in store for the future of gene therapy delivery? By Jason Brauner Biopharma Read More
January 31, 2018 Will the coming wave of gene therapies have a Sovaldi-like impact? By Jason Brauner Biopharma Read More
January 25, 2017 Is Anthem drawing a line in the sand on drug pricing? By Jason Brauner Biopharma Read More
March 20, 2015 Biopharma innovation: Will there be sufficient incentives in the future? By Jason Brauner Biopharma Read More